Halima Salisu Kabara/LinkedIn
Dec 23, 2025, 23:35
Halima Salisu Kabara: Biomarker-Based Assessment for Predicting Sepsis-Induced Coagulopathy and Outcomes in Intensive Care
Halima Salisu Kabara, Practice Development Manager and Health care Services, shared a post on LinkedIn:
“This paper was just published in Academia Medicine and Health!
With Shams ElDoha Galal ElDin Zaiema, Ayat Allah Gamal Ahmed Mohamed Ibrahim Wahab, Manal Fawzy Ghozlan, Yasmin Nabil ElSakhawy, Aya Ali Mahmoud Bayoumy, Heba Samy Agamy”
Title: Biomarker-based assessment for predicting sepsis-induced coagulopathy and outcomes in intensive care
Authors: Shams ElDoha Galal ElDin Zaiema, Ayat Allah Gamal Ahmed Mohamed Ibrahim Wahab, Manal Fawzy Ghozlan, Yasmin Nabil ElSakhawy, Aya Ali Mahmoud Bayoumy, Heba Samy Agamy
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial